30
ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University of Stellenbosch [email protected]

ADIPONECTIN Its emerging role in Atherosclerosis, Metabolic Syndrome and Insulin Resistance RT ERASMUS Chemical Pathology, Tygerberg Hospital, NHLS &University

Embed Size (px)

Citation preview

ADIPONECTINIts emerging role in Atherosclerosis,

Metabolic Syndrome and Insulin Resistance

RT ERASMUS

Chemical Pathology, Tygerberg Hospital,

NHLS &University of Stellenbosch

[email protected]

Discovery and Structure (1)

● Discovered by 4 independent researchers in 1996● More than 1000 papers published mostly from

Japan ● Specific and most abundant in adipocytes● Part of adipokine family (TNFalpha, leptin)● 30 kDa protein; 247 amino acids coded by apM1

gene● Member of collagen family, shares homology with

collagen VIII & X and complement C1q

Copyright ©2005 The Endocrine Society

Kadowaki, T. et al. Endocr Rev 2005;26:439-451

FIG. 1. Structure and domains of adiponectin

Physiology(1)● Expressed and secreted only in adipose tissue

● Endogenous adiponectin post translationally modified into 8 isoforms

● Globular portion as efficient as full length adiponectin at lowering glucose & FFA

● Pulsatile & diurnal secretion similar to other hormones

● Secretion hormone regulated: ↓levels with insulin& glucocorticoids

● TNFα decreases adiponectin transcription

● Elisa &RIA methods available : 5-10 ug/ml

Physiology (2)

● Correlates negatively with BMI & more –vely with visceral than subcut fat

● High levels in plasma (3 x normal conc of other hormones)

● Low levels seen in obesity, type 2 DM, IHD● Levels correlate with insulin sensitivity

Biological Effects (1)

● Insulin- sensitizing actions

● Adiponectin reduces tissue TG content and up regulates insulin signaling through ↑CD36, ↑combustion of fatty acids →↑GLUT4 ( Rx of obese diabetic mice with adiponectin →↑phosphorylation of IRS-1 & insulin receptor)

● Activation of PPARα leading to ↑ fatty acid combustion → ↓tissue FA → ↑ insulin sensitivity (C2C12 myocytes with adiponectin)

Biological effects (2)

● No adiponectin found in normal vessels but in balloon injured vascular walls

● Inhibits adhesion molecules eg E selectin, vascular adhesion mol 1, intracellular adhesion 1

● Inhibits SR-A class of macrophages – decreases uptake of oxidised LDL & thus inhibiting foam cell formation

Polymorphisms in Gene ass with hypoadiponectinaemia, Type 2 DM and Insulin Resistance

● Adiponectin gene, chrom 3, spans 17kb, 3 exons & 2 introns

● Several SNP polymorphisms in Japanese, German and Americans have been identified and ass with Type 2 DM and IR eg SNP 276 and SNP 45(many ass with abnormal forms of adiponectin or low levels)

● This strongly suggests pivotal role of Adiponectin in dev of type DM

Adiponectin Receptors● 2003 : 2 receptors identified:Adipo R1 & R2● Expressed in skeletal muscle and liver● 7 transmembrane proteins● Receptors for both full length & globular

adiponectin● Recently receptors also found in pancreas β

cells● Receptors mediate ↑AMP kinase & PPARγ

activity→ FA oxidation & ↑glucose uptake

Regulation of Adiponectin Receptors● Fasting upregulates expression and refeeding

restores them● Insulin negative regulator – low levels in

insulin resistance● Decreased expression in obesity leading to

decreased adiponectin sensitivity and adiponectin resistance and subsequent insulin resistance setting up a “vicious cycle”

Obesity, adiponectin and insulin resistance

Adiponectin and atherosclerosis

● In cultured cells, human recombinant adiponectin suppresses endothelial expression of adhesion molecules, proliferation of vascular smooth muscle cells & transformation of macrophages to foam cells: adiponectin may thus protect vascular wall against atherogenic changes

● In mice overexpression of adiponectin reduced atherosclerotic plaques

Adiponectin and Insulin Resistance

● Low adiponectin levels seen in obese humans, cardiovascular diseases, hypertension or metablocs syndrome – all of which are ass with IR

● Whether there is cause and effect relationship not known

● Several exp in mice have clearly established the insulin sensitizing effects of adiponectin (along with leptin) as well as the reversal of IRS with recombinant adiponectin – could this be used to treat IR and type 2 DM ?

Adiponectin Hypothesis

● Reduced levels may occur due to genetic(polymorphisms, SNP 276) or environmental factors(obesity,HF diet) and or reduced actions due to down regulation of receptors (obesity)

● These reduced levels may play a causal role in dev IR, MS & progress to atherosclerosis

Conclusion

● Adiponectin specific adipokine produced by adipocytes in large amounts

● Has potent antinflammatory and atheroprotective properties

● Has insulin sensitizing effect influencing glucose and lipid metabolism

● Is associated with insulin resistance and the metabolic syndrome